AI coach aims to ease emotional toll of breast cancer pills
NCT ID NCT07409298
First seen Feb 15, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study looks at whether an artificial intelligence (AI) program can improve anxiety and depression in 300 women with breast cancer who are taking CDK4/6 inhibitor pills at home. Participants will be assigned to one of three groups: an AI-based management model, a customized follow-up model, or standard education and follow-up. The goal is to see which approach best supports mental health and quality of life during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, 300000, China
Conditions
Explore the condition pages connected to this study.